Want to see KR:183490 full AI Analyst Report?
Enzychem Lifesciences Corp. (183490) Income Statement
Enzychem Lifesciences Corp. Income Statement
Last quarter (Q4 2025), Enzychem Lifesciences Corp.'s total revenue was $14.10B, a decrease of 23.87% from the same quarter last year. In Q4, Enzychem Lifesciences Corp.'s net income was $-9.90B. See Enzychem Lifesciences Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 67.75B | $ 77.38B | $ 76.04B | $ 26.64B | $ 22.98B | |
| $ 3.38B | $ 4.31B | $ 4.35B | $ 2.42B | $ 286.72M | |
| $ 16.47B | $ 17.50B | $ 18.70B | $ 17.08B | $ 21.04B | |
| Depreciation and Amortization | $ 3.14B | $ 3.46B | $ 3.51B | $ 2.39B | $ 2.11B |
| $ -14.90B | $ -18.39B | $ -5.75B | $ -13.16B | $ -17.89B | |
| $ -13.09B | $ -13.19B | $ -14.36B | $ -14.66B | $ -20.75B | |
| $ -5.15B | $ -8.89B | $ 4.48B | $ -10.92B | $ -8.75B | |
| $ -18.24B | $ -22.08B | $ -9.88B | $ -25.58B | $ -29.50B | |
| $ -18.13B | $ -22.11B | $ -9.33B | $ -25.09B | $ -27.86B | |
| Per Share Metrics | |||||
| Basic EPS | $ -234.08 | $ -280.50 | $ -110.00 | $ -380.44 | $ -558.47 |
| Diluted EPS | $ -234.08 | $ -280.50 | $ -110.00 | $ -380.44 | $ -558.47 |
| Weighted Average Shares Outstanding | 77.46M | 78.81M | 84.79M | 65.96M | 49.89M |
| Weighted Average Shares Outstanding (Diluted) | 77.46M | 78.81M | 85.07M | 65.96M | 49.89M |
Currency in KRW